These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7367386)

  • 1. [Procetofen in the treatment of hyperlipoproteinaemias (author's transl)].
    Micheli H; Pometta D
    Schweiz Rundsch Med Prax; 1980 Jan; 69(2):42-6. PubMed ID: 7367386
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative research on etofibrate retard and fenofibrate in hyperlipoproteinemia].
    Schwartzkopff W; Schilling A
    Med Welt; 1980 Dec; 31(50):1845-50. PubMed ID: 7464535
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fenofibrate, efficacy and tolerance in long-term treatment (author's transl)].
    Fromantin M; Gautier D; Quatre JM; Bon R
    Therapie; 1981; 36(4):473-6. PubMed ID: 7292431
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
    Micheli H; Pometta D; Gustafson A
    Nouv Presse Med; 1980 Dec; 9(49):3759-62. PubMed ID: 7208343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hyperlipoproteinemia with lipanthyl].
    Kalinová M; Zadák Z; Sobotka L
    Cas Lek Cesk; 1983 Feb; 122(7):205-8. PubMed ID: 6831503
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of fenofibrate on the lipid level in diabetic patients].
    Häring HU; Schleicher E; Renner R; Mehnert H
    MMW Munch Med Wochenschr; 1983 Sep; 125(35):751-3. PubMed ID: 6415427
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etolip and Lipanthyl in the treatment of hyperlipoproteinemia].
    Ceska R; Sobra J; Procházková R; Kvasilová M
    Vnitr Lek; 1990 Apr; 36(4):363-7. PubMed ID: 2356612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lipanthyl in hyperlipoproteinaemic diabetic patients.
    Hajós P; Tornyossi M
    Ther Hung; 1989; 37(3):138-43. PubMed ID: 2588196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the effects of fenofibrate administered in doses of 3 x 100mg and 1 x 250mg per day in patients with type IIA, IIB and IV hyperlipoproteinemias].
    Reiner Z; Salzer B; Kes P
    Acta Med Iugosl; 1988; 42(5):353-62. PubMed ID: 3245481
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the effectiveness of procetofen in the treatment of hypercholesterolemia].
    Kulejewski L; Giec L
    Wiad Lek; 1985 Oct; 38(20):1409-13. PubMed ID: 3913152
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of procetofen on the lipoprotein profile in patients with type II hyperlipoproteinemia].
    Drouin P; Méjean L; Lambert D; Sauvanet JP; Debry G
    Med Welt; 1979 Dec; 30(50):1910-3. PubMed ID: 548697
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of procetofen (lipanthyl) in hyperlipidemias (author's transl)].
    Stähelin HB; Seiler W; Pult N
    Schweiz Rundsch Med Prax; 1979 Jan; 68(1):24-8. PubMed ID: 760103
    [No Abstract]   [Full Text] [Related]  

  • 13. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ; Gutiérrez JA; Menéndez JA; Micó L; Muñoz M; de Oya M
    Clin Ther; 1980; 3(3):219-26. PubMed ID: 7459931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of etofibrate retard, bezafibrate and procetofen.
    Luley C; Schwartzkopff W; Schilling A; Calder D; Scheffler W
    Artery; 1980; 8(2):128-33. PubMed ID: 7458677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy of hyperlipoproteinemias].
    Pometta D
    Ther Umsch; 1980 Feb; 37(2):110-3. PubMed ID: 7385076
    [No Abstract]   [Full Text] [Related]  

  • 16. [level of 7alpha-hydroxycholesterol in blood plasma as an indicator of cholesterol catabolism in hyperlipidemia and with hypolipidemic therapy].
    Poliakova ED; Ivanova TN; Voshchinnikov EI; Olfer'ev AM; Perova NV
    Vopr Med Khim; 2000; 46(2):168-75. PubMed ID: 10885038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience with the hypolipidemic drug Lipanthyl].
    Vaverková H; Kubasta M; Zmeskal A; Vrublovský P; Skrabalová H; Vlcek L
    Vnitr Lek; 1982 Jul; 28(7):698-704. PubMed ID: 7051538
    [No Abstract]   [Full Text] [Related]  

  • 18. [Observations on the short-term effect of Lu-jian (dried bittern) on hyperlipoproteinemia in 94 cases (author's transl)].
    Li ZF
    Zhonghua Xin Xue Guan Bing Za Zhi; 1981 Sep; 9(3):214-5. PubMed ID: 7338178
    [No Abstract]   [Full Text] [Related]  

  • 19. [Low dose clofibrate in the treatment of hypertriglyceridemia in hemodialysis patients (author's transl)].
    Jarillo MD; Coca MC; Díaz Rubio C; Bello I; Gutiérrez-Millet V; Ruilope LM; Rodicio JL; Alvarez Ude F
    Med Clin (Barc); 1980 Nov; 75(8):334-7. PubMed ID: 7442334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolonged probucol treatment in patients with cardiovascular diseases (author's transl)].
    Scebat L; Renais J
    Nouv Presse Med; 1980 Oct; 9(40):3008-10. PubMed ID: 7443441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.